‘Near Impossible’ for Entrepreneurs to Raise Seed Money
According to an article that ran last week in Boston Business Journal, angel investors are looking the other way when entrepreneurs come a-knockin’ for seed […]
Articles by Sara Calabro
Champions Biotechnology to Buy Biomerk
Champions Biotechnology, of Arlington, VA, announced today plans to buy Biomerk, a private company formed just last year to develop its trademark Tumorgrafts, a preclinical […]
ReAble to Acquire IOMED for $22 Million
ReAble, a privately held rehabilitation and orthopedic device company based on Austin, TX, announced today that it would acquire drug-delivery firm IOMED for $22 million […]
Neurotech Investments on the Rise
Venture capitalists pumped nearly $1.7 billion into neurotechnology in 2006, according to a report released today that paints the field as a frontier industry on […]
CoreValve Out in Front with Non-Invasive Heart Valve
CoreValve received CE Mark approval yesterday for its non-invasive heart valve, putting the Irvine, CA, company out in front of other startups working on similar technologies. The company’s ReValving System […]
Amedica Secures $13.2 Million in Series D Financing
Amedica, a Salt Lake City, UT, company that makes orthopedic implants, today announced that it has raised $13.2 million in Series D financing. Including this round, for […]
Teknimed Inks Deal with Smith & Nephew
Teknimed, a privately held French company that makes biomaterials for bone surgery, has signed a deal to allow Smith & Nephew to market its FDA-approved […]
CEO Says Private Placement Forgives ‘Hiccups’
Bruce Kehr, CEO of Rockville, MD-based InforMedix, thinks private placement funding is worth the wait. The neuropsychiatrist turned CEO recently explained to the Washington Business […]
BlueSky May Make $110 Million off Smith & Nephew Deal
The two founders of BlueSky Medical Group, a private med tech company based in Carlsbad, CA, stand to make up to $110 million off a deal […]
Schwarz Out in Front with Parkinson’s Patch
Schwarz Pharma today received FDA approval for Neupro, its transdermal patch for treatment of early-stage Parkinson’s disease. Neupro has been on the market in Europe […]